Yahoo Finance

BURNABY, British Columbia (AP) — BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $65.7 million in its fourth quarter.

On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 84 cents.

The results beat Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 89 cents per share.

For the year, the company reported a loss of $234.3 million, or $3.01 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENE at https://www.zacks.com/ap/XENE